Impax Laboratories, Inc. (NASDAQ:IPXL) Posts Basic Consolidated EPS Of $0.56

0

Impax Laboratories, Inc. (NASDAQ:IPXL)managed to report annual basic consolidated EPS of $0.56, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $0.56 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.038.

EPS contribution from parent

Impax Laboratories, Inc. (NASDAQ:IPXL) received of $0.56 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Impax Laboratories, Inc. (NASDAQ:IPXL) contributed EPS of $0.56 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $0.56.

What About Basic net EPS

The basic net EPS that Impax Laboratories, Inc. (NASDAQ:IPXL) reported for the year ended 2015-12-31 stood at $0.56. For the quarter ended 2015-12-31, the company posted basic net EPS of $0.56.

What About Consolidated Diluted EPS?

Impax Laboratories, Inc. (NASDAQ:IPXL)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $0.5414. For the quarter ended 2015-12-31 the metric was$0.5414.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $0.5414 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $0.5414.

Net diluted EPS

Net diluted EPS posted by Impax Laboratories, Inc. (NASDAQ:IPXL) for the year ended 2015-12-31 was $0.54. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $0.54.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Impax Laboratories, Inc. (NASDAQ:IPXL) said that it parent company boosted its diluted EPS by$0.5414 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $0.5414.

The company reported net basic EPS of $0.56 for the year ended 2015-12-31 and net basic EPS of $0.56 for the quarter ended 2015-12-31.

The number of Impax Laboratories, Inc. (NASDAQ:IPXL)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 69.64. That compares with 69.64 basic shares outstanding for the quarter ended 2015-12-31.

Impax Laboratories, Inc. (NASDAQ:IPXL) had 72.027 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 72.027.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 22 times, 1 visits today)